Oppenheimer reiterates Compass Pathways stock rating on FDA progress
2 sources
·2d ago
← All stories
COMPASS Pathways
British biotechnology company developing psilocybin-based treatments for mental health disorders
- HQ
- CHESIRE, X0
- Industry
- Pharmaceutical Preparations
In the news · 1
More in Healthcare